NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.95
0.05 (2.63%)
At close: Jul 03, 2025, 3:32 PM
1.90
-2.56%
After-hours: Jul 03, 2025, 04:28 PM EDT
2.63% (1D)
| Bid | 1.9 |
| Market Cap | 46.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.21M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -3.61 |
| Forward PE | -9.5 |
| Analyst | Hold |
| Ask | 1.95 |
| Volume | 85,761 |
| Avg. Volume (20D) | 276,411 |
| Open | 1.88 |
| Previous Close | 1.90 |
| Day's Range | 1.84 - 1.95 |
| 52-Week Range | 0.51 - 2.60 |
| Beta | 1.60 |
About NRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+12.28%
NeuroSense Therapeutics shares are trading higher....
Unlock content with
Pro Subscription
7 months ago
+14.27%
NeuroSense Therapeutics shares are trading higher after the company announced its CEO purchased $5 million worth of ordinary shares in a private placement.
